BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16239547)

  • 1. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae.
    van der Graaf CA; Netea MG; Verschueren I; van der Meer JW; Kullberg BJ
    Infect Immun; 2005 Nov; 73(11):7458-64. PubMed ID: 16239547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction.
    Netea MG; Warris A; Van der Meer JW; Fenton MJ; Verver-Janssen TJ; Jacobs LE; Andresen T; Verweij PE; Kullberg BJ
    J Infect Dis; 2003 Jul; 188(2):320-6. PubMed ID: 12854089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
    Netea MG; Van Der Graaf CA; Vonk AG; Verschueren I; Van Der Meer JW; Kullberg BJ
    J Infect Dis; 2002 May; 185(10):1483-9. PubMed ID: 11992285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of nuclear factor- kappa B and c-Jun/activator protein-1 via toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans.
    Roeder A; Kirschning CJ; Schaller M; Weindl G; Wagner H; Korting HC; Rupec RA
    J Infect Dis; 2004 Oct; 190(7):1318-26. PubMed ID: 15346344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida albicans phospholipomannan is sensed through toll-like receptors.
    Jouault T; Ibata-Ombetta S; Takeuchi O; Trinel PA; Sacchetti P; Lefebvre P; Akira S; Poulain D
    J Infect Dis; 2003 Jul; 188(1):165-72. PubMed ID: 12825186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis.
    van der Graaf CA; Netea MG; Drenth IP; te Morsche RH; van der Meer JW; Kullberg BJ
    Neth J Med; 2003 Nov; 61(11):365-9. PubMed ID: 14768719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines.
    Villamón E; Gozalbo D; Roig P; Murciano C; O'Connor JE; Fradelizi D; Gil ML
    Eur Cytokine Netw; 2004; 15(3):263-71. PubMed ID: 15542452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 2 mediates prostaglandin E(2) production in murine peritoneal macrophages and splenocytes in response to Candida albicans.
    Villamón E; Roig P; Gil ML; Gozalbo D
    Res Microbiol; 2005; 156(1):115-8. PubMed ID: 15636756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis.
    Riordan SM; Skinner N; Nagree A; McCallum H; McIver CJ; Kurtovic J; Hamilton JA; Bengmark S; Williams R; Visvanathan K
    Hepatology; 2003 May; 37(5):1154-64. PubMed ID: 12717397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
    Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
    Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endogenous interleukin (IL)-18, IL-12, IL-1beta, and tumor necrosis factor-alpha in the production of interferon-gamma induced by Candida albicans in human whole-blood cultures.
    Netea MG; Stuyt RJ; Kim SH; Van der Meer JW; Kullberg BJ; Dinarello CA
    J Infect Dis; 2002 Apr; 185(7):963-70. PubMed ID: 11920321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas-FasL interactions modulate host defense against systemic Candida albicans infection.
    Netea MG; van Der Meer JW; Meis JF; Kullberg BJ
    J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways.
    Netea MG; Kullberg BJ; Galama JM; Stalenhoef AF; Dinarello CA; Van der Meer JW
    Eur J Immunol; 2002 Apr; 32(4):1188-95. PubMed ID: 11932927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors as an escape mechanism from the host defense.
    Netea MG; Van der Meer JW; Kullberg BJ
    Trends Microbiol; 2004 Nov; 12(11):484-8. PubMed ID: 15488388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis.
    Villamón E; Gozalbo D; Roig P; O'Connor JE; Ferrandiz ML; Fradelizi D; Gil ML
    Microbes Infect; 2004 May; 6(6):542-8. PubMed ID: 15158187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.
    Netea MG; Sutmuller R; Hermann C; Van der Graaf CA; Van der Meer JW; van Krieken JH; Hartung T; Adema G; Kullberg BJ
    J Immunol; 2004 Mar; 172(6):3712-8. PubMed ID: 15004175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.